Natural Product: NPC50504

Natural Product IDNPC50504
Common Name
?
The InCHIKey will be temporarily assigned as the "Common Name" if no IUPAC name or alternative short name is available.
TXLQONQJSWSJJX-CMWLGVBASA-N
IUPAC Name n.a.
Synonyms
Synthetic Gene Cluster n.a.
ChEMBL Identifier n.a.
PubChem CID 14583643
Chemical Classification
  • CHEMONTID:0000000 [Organic compounds]
    • [CHEMONTID:0000261] Phenylpropanoids and polyketides
      • [CHEMONTID:0002506] Isoflavonoids
        • [CHEMONTID:0000507] Isoflavonoid O-glycosides

The Chemical Classification was calculated by Classyfire, a software for chemical taxonomy calculation. Reference: DOI:10.1186/s13321-016-0174-y.

  Chemical Representations

Standard InCHIKey TXLQONQJSWSJJX-CMWLGVBASA-N
Standard InCHI InChI=1S/C21H20O10/c22-7-15-18(26)19(27)20(28)21(31-15)30-14-6-11(24)5-13-16(14)17(25)12(8-29-13)9-1-3-10(23)4-2-9/h1-6,8,15,18-24,26-28H,7H2/t15-,18-,19+,20-,21-/m1/s1
SMILES c1cc(ccc1c1coc2cc(cc(c2c1=O)O[C@H]1[C@@H]([C@H]([C@@H]([C@@H](CO)O1)O)O)O)O)O

  Calculated Properties

Physi-Chem Properties

Molecular Weight:   432.11 Volume:   404.357
?
Van der Waals volume.
Dense:   1.069 LogP:   0.612
?
The logarithm of the n-octanol/water distribution coefficients.
logD7.4:   1.18
?
The logarithm of the n-octanol/water distribution coefficient at pH=7.4.
LogS:   -2.931
?
The logarithm of aqueous solubility value.
Rotatable Bonds:   4.0 Rigid Bonds:   24.0
TPSA:   170.05
?
Topological Polar Surface Area.
H-Bond Acceptor:   10.0
H-Bond Donor:   6.0 Rings:   4.0
Heavy Atoms:   10.0

MedChem Properties

QED Drug-Likeness Score:   0.331 GASA:   0.0
?
GASA represents the probability of being difficult to synthesize, ranging from 0 to 1.
Synthetic Accessibility Score:   3.876 Fsp3:   0.286
MCE-18:   84.259
?
MCE-18 stands for medicinal chemistry evolution.MCE-18≥45 is considered a suitable value.
Lipinski Rule-of-5:   Rejected
Pfizer Rule:   Rejected GSK Rule:   Accepted
Golden Triangle Rule:   Rejected BMS Rule:   0
Chelating Alert:   0 PAINS Alert:   0
Colloidal aggregators:   0.576 Fluc inhibitor:   0.271
?
The fluc inhibitor value is the probability of being fLuc inhibitors, within the range of 0 to 1.
Blue fluorescence:   0.838
?
The blue fluorescence value is the probability of being blue fluorescence, within the range of 0 to 1
Green fluorescence:   0.671
?
The green fluorescence value is the probability of being green fluorescence, within the range of 0 to 1
Reactive compounds:   0.258 Promiscuous compounds:   0.372

ADMET Properties (ADMETlab3.0)

ADMET: Absorption

Caco-2 Permeability:   -6.403 MDCK Permeability:   -5.064
Pgp-inhibitor:   0.0 Pgp-substrate:   0.18
PAMPA:   0.997
?
The experimental data for Peff was logarithmically transformed (logPeff). Molecules with log Peff values below 2.0 were classified as low-permeability (Category 0), while those with log Peff values exceeding 2.5 were classified as high-permeability (Category 1).
Human Intestinal Absorption (HIA):   0.213
20% Bioavailability (F20%):   0.547 30% Bioavailability (F30%):   0.963
50% Bioavailability (F50%):   0.986

ADMET: Distribution

Blood-Brain-Barrier Penetration (BBB):   0.02 MRP1:   0.094
Plasma Protein Binding (PPB):   82.537% Volume Distribution (VD):   -0.116
Fu: 18.001%
?
The fraction unbound in plasms.
OATP1B1 inhibitor:   0.985
OATP1B3 inhibitor:   0.978 BCRP inhibitor:   0.156
BSEP inhibitor:   0.01

ADMET: Metabolism

CYP1A2-inhibitor:   0.831 CYP1A2-substrate:   0.0
CYP2C19-inhibitor:   0.0 CYP2C19-substrate:   0.001
CYP2C9-inhibitor:   0.0 CYP2C9-substrate:   0.005
CYP2D6-inhibitor:   0.009 CYP2D6-substrate:   0.03
CYP3A4-inhibitor:   0.0 CYP3A4-substrate:   0.071
CYP2B6-substrate:   0.0 CYP2C8-inhibitor:   0.998
HLM stability:   0.0
?
Human liver microsomal (HLM) stability. Category 0: stable+ (HLM > 30 min); Category 1: unstable- (HLM ≤ 30 min). The output value is the probability of human liver microsomal instability, where a value closer to 1 indicates a higher likelihood of instability.

ADMET: Excretion

Clearance (CL):  3.274 Half-life (T1/2):  3.398

ADMET: Toxicity

hERG Blockers:  0.051 hERG Blockers (10um):  0.168
Human Hepatotoxicity (H-HT):  0.693 Drug-induced Liver Injury (DILI):  0.908
AMES Toxicity:  0.864 Rat Oral Acute Toxicity:  0.063
Maximum Recommended Daily Dose:  0.153 Skin Sensitization:  0.988
Carcinogencity:  0.427 Eye Corrosion:  0.0
Eye Irritation:  0.558 Respiratory Toxicity:  0.035
Drug-induced Neurotoxicity:  0.029 Ototoxicity:  0.87
Hematotoxicity:  0.124 Drug-induced Nephrotoxicity:  0.437
Genotoxicity:  0.94 RPMI-8226 Immunitoxicity:  0.062
A549 Cytotoxicity:  0.299 Hek293 Cytotoxicity:  0.571
BCF:   0.407
?
Bioconcentration factors are used for considering secondary poisoning potential and assessing risks to human health via the food chain. The unit is -log10[(mg/L)/(1000*MW)].
IGC50:   2.953
?
48 hour Tetrahymena pyriformis IGC50. The unit of IGC50 is -log10[(mg/L)/(1000*MW)].
LC50DM:   4.282
?
48 hour Daphnia magna LC50. The unit of LC50DM is -log10[(mg/L)/(1000*MW)].
LC50FM:   3.519
?
96 hour fathead minnow LC50. The unit of LC50FM is -log10[(mg/L)/(1000*MW)].

  Species Source

Organism ID Organism Name Taxonomy Level Family SuperKingdom Isolation Part Collection Location Collection Time Reference
NPO26828 Barbarea verna Species Brassicaceae Eukaryota n.a. n.a. n.a. Database[COCONUT]
NPO25482 Phyllogeiton zeyheri n.a. n.a. n.a. n.a. n.a. n.a. Database[COCONUT]
NPO23780 Psoroma crassum Species Pannariaceae Eukaryota n.a. n.a. n.a. Database[UNPD]
NPO26183 Scabiosa pyrenaica Species Caprifoliaceae Eukaryota n.a. n.a. n.a. Database[UNPD]
NPO26828 Barbarea verna Species Brassicaceae Eukaryota n.a. n.a. n.a. Database[UNPD]
NPO25482 Phyllogeiton zeyheri n.a. n.a. n.a. n.a. n.a. n.a. Database[UNPD]
NPO2201 Orthocaulis attenuatus Species Anastrophyllaceae Eukaryota n.a. n.a. n.a. Database[UNPD]
NPO25532 Blitum virgatum Species Chenopodiaceae Eukaryota n.a. n.a. n.a. Database[UNPD]

Note for Reference:
In addition to directly collecting NP source organism data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated them from below databases:
UNPD: Universal Natural Products Database [PMID: 23638153].
StreptomeDB: a database of streptomycetes natural products [PMID: 33051671].
TM-MC: a database of medicinal materials and chemical compounds in Northeast Asian traditional medicine [PMID: 26156871].
TCM@Taiwan: a Traditional Chinese Medicine database [PMID: 21253603].
TCMID: a Traditional Chinese Medicine database [PMID: 29106634].
TCMSP: The traditional Chinese medicine systems pharmacology database and analysis platform [PMID: 24735618].
HerDing: a herb recommendation system to treat diseases using genes and chemicals [PMID: 26980517].
MetaboLights: a metabolomics database [PMID: 27010336].
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].



  NP Quantity Composition/Concentration

Organism ID Organism Name Organism Material Preparation Organism Part NP Quantity (Standard) NP Quantity (Minimum) NP Quantity (Maximum) Quantity Unit Reference

Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP quantitative records for specific NP domains (e.g., NPS from foods or herbs) from domain-specific databases. These databases include:
DUKE: Dr. Duke's Phytochemical and Ethnobotanical Databases.
PHENOL EXPLORER: is the first comprehensive database on polyphenol content in foods [PMID: 24103452], its homepage can be accessed at here.
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].



 Biological Activity

Molecular-level activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference

In vitro activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference

In vivo activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference





 Experimental ADME

Experiment Model Experiment Tissue ADME Type ADME Relation ADME Value ADME Unit Reference





 Experimental Toxicity

Quantitative toxicity

Experiment Model Experiment Organism Toxicity Type Toxicity Relation Toxicity Value Toxicity Unit Reference

Common Abbreviations:
LC: Lethal Concentration; LD: Lethal Dose; LT:Lethal Time; NOAEL: No-observed-adverse-effect Level; BMDL: Benchmark Dose Lower Confidence Limit; BMD: Benchmark Dose; BMC:Benchmark Concentration; LOAEL: Lowest Observed Adverse Effect Level; RfD:Reference Dose; RfC:Reference Concentration; MRL: Minimal Risk Level; MEG: Maximum Exposure Guideline; PAC: Protective Action Criteria

Categorical toxicity labels

Hepatotoxicity Carcinogenicity Mutagenicity Cardiotoxicity Respiratory Toxicity Eye Irritation Endocrine Disruption
Hepatotoxicity Carcinogenicity Mutagenicity Cardiotoxicity Respiratory Toxicity Eye Irritation Endocrine Disruption

Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP toxicity records from domain-specific databases. These databases include:
ToxValDB: a curated database that compiles quantitative toxicity values for chemicals from diverse public sources to support toxicological research and risk assessment.
TOXRIC: a comprehensive, free-to-access, online database providing toxicological/feature data. The toxicity labels are retrieved from this database. [PMID: 36400569]


  Chemically structural similarity

Similar Active Natural Products in NPASS

Top-200 similar NPs were calculated against the active-NP-set (includes approximately 50,000 NPs with experimentally-derived bioactivity available in NPASS)

Similarity is measured using the Tanimoto coefficient (Tc) , which compares the binary fingerprints of two molecules. Tc is calculated as the intersection divided by the union of '1' bits in the fingerprints, ranging from 0 to 1, with 1 indicating highest similarity.

●  The left chart: Distribution of similarity level between NPC50504 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.5 or Top200).

Similarity Score Similarity Level Natural Product ID
0.76 Intermediate Similarity NPC100720
0.7273 Intermediate Similarity NPC479401
0.7105 Intermediate Similarity NPC197896
0.7105 Intermediate Similarity NPC313163
0.6883 Remote Similarity NPC105511
0.6883 Remote Similarity NPC161749
0.6753 Remote Similarity NPC83283
0.6709 Remote Similarity NPC205076
0.6667 Remote Similarity NPC258035
0.6456 Remote Similarity NPC156457
0.6386 Remote Similarity NPC479407
0.6324 Remote Similarity NPC7013
0.6265 Remote Similarity NPC479406
0.625 Remote Similarity NPC609879
0.6125 Remote Similarity NPC348541
0.6024 Remote Similarity NPC479402
0.6023 Remote Similarity NPC479405
0.5976 Remote Similarity NPC73511
0.5955 Remote Similarity NPC479404
0.5926 Remote Similarity NPC259070
0.5926 Remote Similarity NPC211014
0.5904 Remote Similarity NPC138540
0.5833 Remote Similarity NPC481043
0.5833 Remote Similarity NPC80140
0.5714 Remote Similarity NPC222936
0.5714 Remote Similarity NPC599850
0.5632 Remote Similarity NPC48773
0.561 Remote Similarity NPC45165
0.561 Remote Similarity NPC135345
0.5476 Remote Similarity NPC234739
0.5402 Remote Similarity NPC229729
0.5341 Remote Similarity NPC307518
0.5326 Remote Similarity NPC303913
0.5294 Remote Similarity NPC603782
0.5287 Remote Similarity NPC224462
0.5263 Remote Similarity NPC109187
0.525 Remote Similarity NPC78697
0.5238 Remote Similarity NPC160515
0.5176 Remote Similarity NPC77672
0.5176 Remote Similarity NPC133671
0.5176 Remote Similarity NPC135391
0.5176 Remote Similarity NPC78263
0.5176 Remote Similarity NPC250069
0.5116 Remote Similarity NPC323593
0.5116 Remote Similarity NPC203500
0.5057 Remote Similarity NPC100818
0.5057 Remote Similarity NPC610763
0.5056 Remote Similarity NPC601607

Similar Clinical/Approved Drugs

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.

●  The left chart: Distribution of similarity level between NPC50504 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.5 or Top200).

Similarity Score Similarity Level Drug ID Developmental Stage
0.6883 Remote Similarity NPD4381 Clinical (unspecified phase)
0.561 Remote Similarity NPD3818 Discontinued

Bioactivity similarity

  Bioactivity similarity

Similar Natural Products in NPASS

Similarity level is defined by Bioactivity similarity was calculated based on bioactivity descriptors of compounds. The bioactivity descriptors were calculated by a recently developed AI algorithm Chemical Checker (CC) [Nature Biotechnology, 38:1087–1096, 2020; Nature Communications, 12:3932, 2021], which evaluated bioactivity similarities at five levels:
A: chemistry similarity;
B: biological targets similarity;
C: networks similarity;
D: cell-based bioactivity similarity;
E: similarity based on clinical data.
Those 5 categories of CC bioactivity descriptors were calculated and then subjected to manifold projection using UMAP algorithm, to project all NPs on a 2-Dimensional space. The current NP was highlighted with a small circle in the 2-D map. Below figures: left-to-right, A-to-E.

A: chemistry similarity
B: biological targets similarity
C: networks similarity
D: cell-based bioactivity similarity
E: similarity based on clinical data